Flavocoxid may cause clinically significant liver injury in some patients, according to study results published in the Annals of Internal Medicine. Flavocoxid is a medical food, marketed under the name of Limbrel, for the treatment of osteoarthritis.
Researchers linked 4 cases of liver injury to flavocoxid, based on
the records of 877 patients followed by the national Drug-Induced Liver
Injury Network. All four people developed signs of liver injury within
one to 3 months of starting flavocoxid. The connection to flavocoxid use
was considered very likely in 3 of the 4 cases and possible in one of
the cases. The good news is that once the product is stopped, liver
problems resolve within weeks.
Read more...
No comments:
Post a Comment